BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 12091880)

  • 1. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.
    Hattori K; Heissig B; Wu Y; Dias S; Tejada R; Ferris B; Hicklin DJ; Zhu Z; Bohlen P; Witte L; Hendrikx J; Hackett NR; Crystal RG; Moore MA; Werb Z; Lyden D; Rafii S
    Nat Med; 2002 Aug; 8(8):841-9. PubMed ID: 12091880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment.
    Rafii S; Avecilla S; Shmelkov S; Shido K; Tejada R; Moore MA; Heissig B; Hattori K
    Ann N Y Acad Sci; 2003 May; 996():49-60. PubMed ID: 12799282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.
    Hattori K; Dias S; Heissig B; Hackett NR; Lyden D; Tateno M; Hicklin DJ; Zhu Z; Witte L; Crystal RG; Moore MA; Rafii S
    J Exp Med; 2001 May; 193(9):1005-14. PubMed ID: 11342585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.
    Heissig B; Hattori K; Dias S; Friedrich M; Ferris B; Hackett NR; Crystal RG; Besmer P; Lyden D; Moore MA; Werb Z; Rafii S
    Cell; 2002 May; 109(5):625-37. PubMed ID: 12062105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating the effects of 5-fluorouracil and follicle-stimulating hormone on mouse bone marrow stem/progenitor cells.
    Shaikh A; Bhartiya D; Kapoor S; Nimkar H
    Stem Cell Res Ther; 2016 Apr; 7(1):59. PubMed ID: 27095238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies.
    Eriksson U; Alitalo K
    Nat Med; 2002 Aug; 8(8):775-7. PubMed ID: 12152025
    [No Abstract]   [Full Text] [Related]  

  • 7. KDR receptor: a key marker defining hematopoietic stem cells.
    Ziegler BL; Valtieri M; Porada GA; De Maria R; Müller R; Masella B; Gabbianelli M; Casella I; Pelosi E; Bock T; Zanjani ED; Peschle C
    Science; 1999 Sep; 285(5433):1553-8. PubMed ID: 10477517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.
    Christensen JL; Weissman IL
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14541-6. PubMed ID: 11724967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.
    Lyden D; Hattori K; Dias S; Costa C; Blaikie P; Butros L; Chadburn A; Heissig B; Marks W; Witte L; Wu Y; Hicklin D; Zhu Z; Hackett NR; Crystal RG; Moore MA; Hajjar KA; Manova K; Benezra R; Rafii S
    Nat Med; 2001 Nov; 7(11):1194-201. PubMed ID: 11689883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
    Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Flk-1 in mouse hematopoietic stem cells.
    Haruta H; Nagata Y; Todokoro K
    FEBS Lett; 2001 Oct; 507(1):45-8. PubMed ID: 11682057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
    Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
    Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
    Clauss M; Weich H; Breier G; Knies U; Röckl W; Waltenberger J; Risau W
    J Biol Chem; 1996 Jul; 271(30):17629-34. PubMed ID: 8663424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
    Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness.
    Bradley HL; Couldrey C; Bunting KD
    Blood; 2004 Apr; 103(8):2965-72. PubMed ID: 15070672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1lo Lin-Sca-1+ hematopoietic stem cells.
    Uchida N; Aguila HL; Fleming WH; Jerabek L; Weissman IL
    Blood; 1994 Jun; 83(12):3758-79. PubMed ID: 7911343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
    Mac Gabhann F; Popel AS
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
    Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
    Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
    Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
    Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
    Fleming WH; Mulcahy JM; McKearn JP; Streeter PR
    Exp Hematol; 2001 Aug; 29(8):943-51. PubMed ID: 11495700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.